Re-Evaluating PIN1 as a Therapeutic Target in Oncology Using Neutral Inhibitors and PROTACs
Journal of Medicinal Chemistry · 12.09.2024 · 67 (17) · 15780-15795
DOI: 10.1021/acs.jmedchem.4c01412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 04.09.2024. Verfasst von Chuan Liu und 20 weiteren Autor:innen. Beteiligte Einrichtung: HitGen Inc., Shuangliu District, Chengdu, Sichuan 610200, P. R. China. Hauptthemen laut MEDLINE: NIMA-Interacting Peptidylprolyl Isomerase, Antineoplastic Agents, Cell Proliferation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- HitGen Inc., Shuangliu District, Chengdu, Sichuan 610200, P. R. China.
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Wenjiang District, Chengdu, Sichuan 611138, P. R. China.
ORCID-Profile: Guansai Liu, Dengfeng Dou
Zitieren
APA
Liu, C., Chen, Z., Chen, T., Song, H., Shen, J., Yuan, X., Xia, S., Liu, Q., Chen, Q., Tian, Q., Meng, X., Han, Z., Dong, X., Yang, Y., Cai, L., Cheng, X., Jia, Y., Liu, G., Li, J., …, & Dou, D. (2024). Re-Evaluating PIN1 as a Therapeutic Target in Oncology Using Neutral Inhibitors and PROTACs. Journal of Medicinal Chemistry, 67(17), 15780-15795. https://doi.org/10.1021/acs.jmedchem.4c01412
Vancouver
Liu C, Chen Z, Chen T, Song H, Shen J, Yuan X, et al. Re-Evaluating PIN1 as a Therapeutic Target in Oncology Using Neutral Inhibitors and PROTACs. Journal of Medicinal Chemistry. 2024;67(17):15780-15795. doi:10.1021/acs.jmedchem.4c01412
BibTeX
@article{Liu2024,
author = {Liu, Chuan and Chen, Zhonghui and Chen, Tao and Song, Hongmei and Shen, Jianbo and Yuan, Xiaoxi and Xia, Shuai and Liu, Qian and Chen, Qiuxia and Tian, Qiang and Meng, Xiaoyun and Han, Zhu and Dong, Xiaofei and Yang, Yu and Cai, Longying and Cheng, Xuemin and Jia, Yangyang and Liu, Guansai and Li, Jin and Ge, Junyou and Dou, Dengfeng},
title = {Re-Evaluating PIN1 as a Therapeutic Target in Oncology Using Neutral Inhibitors and PROTACs},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {17},
pages = {15780--15795},
doi = {10.1021/acs.jmedchem.4c01412}
}
EUVIMED